Diabetes

Highlights include: POC A1c testing in prediabetes screening, first-year weight loss after bariatric surgery, and predicting fracture risk in obese patients. 

A tooth-mounted sensor, a glucose monitor built into a smartphone case, plus 3 more new “gee whiz” devices that could transform diabetes care.

Hypoglycemic episodes are uncomfortable, disruptive, and dangerous; 3 ways to help T2DM patients avoid and also correct them.

New long-acting insulin products are winning preferred formulary status, pushing old standards aside. Here, pointers on the new options. 

Treatment for erectile dysfunction may finally be affordable, available, and convenient.   

A 52-year-old woman with T2DM is on metformin, works with a dietitian, and exercises regularly, but her hemoglobin A1c has increased. What would you advise? 

The "new year" is now in full swing and new drugs are being approved each month; check out our slideshow to get up to date on 9 drugs approved in the first quarter for primary care. 

How would you handle a patient's misconceptions about insulin? Or discuss a series of wild glucose readings? Take our 5-question quiz to find out.

Since aldosterone has become a pivotal hypertensive hormone, screening with or without confirmation should be part of primary care practice. Here's a straightforward approach.

Attention to a few easily obtained details can prevent serious sequelae in patients with T2 diabetes complicated by cardiovascular and renal disease.

This study demonstrated that in patients with type 2 diabetes mellitus, use of β-blockers was associated with an increased risk for cardiovascular events and severe hypoglycemia. Details here.

Here: a quick look at newly approved agents for primary care that will soon be coming your way.

A new meta-analysis finds that routine intake of artificial sweeteners is linked to weight gain and metabolic dysfunction. Wait, what? 

Apps to guide osteoporosis treatment, insulin management, endocrine emergencies, plus ADA and Endo Society standards of care, at-a-glance.

A first-of-its-kind study reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are gender differences.

Chronic renal disease is common in primary care settings and so are its comorbidities. In brief here, 5 apps you might want at hand.

Providers may now be paid up to $785 (increased from $450) for each patient who loses 5% of their body weight.

Study: each gain of 5 kg was linked to a 17% drop in odds of healthy aging. A powerful message for young patients.

Results from studies on the asthma-diabetes connection are inconsistent. A novel analysis may help clarify directionality.

Can you identify the cause of the hyperpigmented umbilicated lesions seen bilaterally on the patient's extremities and on her back?

Studies summarized in this slide show focus on fine-tuning insulin-containing regimens to enhance glucose control and avoid variability.

Test your knowledge of the products of climate change and the health effects they may have.

Glycemic variability fuels hypoglycemia but in one study from ADA 2017 is found to actually help predict hypoglycemic events.

Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.

A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.